RElapse in previously irradiated Prostate bed : a phase I/II study of stereotactic Ablative reIRradiation potentiated by Metformine (REPAIR GETUG P16)
ICO-2020-01 REPAIR
Phase 2 other active
Quick answer
RElapse in previously irradiated Prostate bed : a phase I/II study of stereotactic Ablative reIRradiation potentiated by Metformine (REPAIR GETUG P16) for RElapse in previously irradiated Prostate bed is a Phase 2 program (other) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- RElapse in previously irradiated Prostate bed
- Phase
- Phase 2
- Modality
- other
- Status
- active